KAYLEE FRANKS: Open Payments
NPI 1982000683 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 32 payments from 7 companies in 2025. Trend: 2023 $807 · 2024 $915 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $568 |
| Janssen Biotech, Inc. | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| Lilly USA, LLC | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
Products named: SKYRIZI, TREMFYA, RINVOQ, ENTYVIO, CREON, OMVOH, TERLIVAZ, OCALIVA.
Industry payments across TX — which companies pay providers there.
